Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1966 1
1969 2
1982 1
1983 1
1989 1
1992 1
2001 1
2003 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
The high-altitude brain.
Hornbein TF. Hornbein TF. J Exp Biol. 2001 Sep;204(Pt 18):3129-32. J Exp Biol. 2001. PMID: 11581326 Free article. Review.
In this paper, I will explore the possibility that what limits human performance at such extreme degrees of hypoxia is the availability of oxygen to the brain. ...I will speculate about physiological mechanisms that might cause or contribute to both decrements in real-time …
In this paper, I will explore the possibility that what limits human performance at such extreme degrees of hypoxia is the availabili …
A tribute to John Wendell Severinghaus.
Hornbein TF. Hornbein TF. Adv Exp Med Biol. 2003;543:1-6. doi: 10.1007/978-1-4419-8997-0_1. Adv Exp Med Biol. 2003. PMID: 14713110 No abstract available.
The cost to the central nervous system of climbing to extremely high altitude.
Hornbein TF, Townes BD, Schoene RB, Sutton JR, Houston CS. Hornbein TF, et al. N Engl J Med. 1989 Dec 21;321(25):1714-9. doi: 10.1056/NEJM198912213212505. N Engl J Med. 1989. PMID: 2512483
To assess the possibility that climbing to extremely high altitude may result in hypoxic injury to the brain, we performed neuropsychological and physiologic testing on 35 mountaineers before and 1 to 30 days after ascent to altitudes between 5488 and 8848 m, and on 6 subj …
To assess the possibility that climbing to extremely high altitude may result in hypoxic injury to the brain, we performed neuropsych …
Acute mountain sickness and acetazolamide. Clinical efficacy and effect on ventilation.
Larson EB, Roach RC, Schoene RB, Hornbein TF. Larson EB, et al. Among authors: Hornbein TF. JAMA. 1982 Jul 16;248(3):328-32. JAMA. 1982. PMID: 7045433 Clinical Trial.
Sixty-four climbers participated in a randomized clinical trial of acetazolamide prophylaxis for acute mountain sickness (AMS) during rapid, active ascent of MT Rainier. ...Increased ventilation at altitude, producing an increased alveolar oxygen tension, may be rel …
Sixty-four climbers participated in a randomized clinical trial of acetazolamide prophylaxis for acute mountain sickness (AMS) during …
Long term effects of high altitude on brain function.
Hornbein TF. Hornbein TF. Int J Sports Med. 1992 Oct;13 Suppl 1:S43-5. doi: 10.1055/s-2007-1024589. Int J Sports Med. 1992. PMID: 1483787
Can the wanderer to the limits of earth-bound hypoxia suffer similar harm from more prolonged exposure to milder hypoxia that does not cause loss of consciousness? ...Limited evidence suggests that climbers with a high ventilatory response to hypoxia (HVR) ma …
Can the wanderer to the limits of earth-bound hypoxia suffer similar harm from more prolonged exposure to milder hypoxia that …
Acute mountain sickness, antacids, and ventilation during rapid, active ascent of Mount Rainier.
Roach RC, Larson EB, Hornbein TF, Houston CS, Bartlett S, Hardesty J, Johnson D, Perkins M. Roach RC, et al. Among authors: Hornbein TF. Aviat Space Environ Med. 1983 May;54(5):397-401. Aviat Space Environ Med. 1983. PMID: 6347173 Clinical Trial.
Rainier was conducted to test the effectiveness of antacids in preventing acute mountain sickness. All 45 climbed to 3353 m, and 31 continued to the summit. ...The results of this study fail to document efficacy for antacid use for the prevention of acute mountain sickn
Rainier was conducted to test the effectiveness of antacids in preventing acute mountain sickness. All 45 climbed to 3353 m, and 31 c …
Feedback